MDA (Medical Devices Agency) calls for better resourcing of surveillance controls

There must be concern at the level of resources afforded to [the implementation of post-market surveillance legislation] in many EU member states." This is how David Jefferys, chief executive of the UK Medical Devices Agency, addressed the recent annual meeting of the British Healthcare Trades Association (BHTA), in answer to the industry's concerns at the "variability in performance" of the notified bodies and the quality of imported medical devices, especially in the assistive technologies field.